Platelets as Modulators of Cerebral Ischemia/Reperfusion Injury
Open Access
- 1 November 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 10, 2505
- https://doi.org/10.3389/fimmu.2019.02505
Abstract
Ischemic stroke is among the leading causes of disability and death worldwide. In acute ischemic stroke, the rapid recanalization of occluded cranial vessels is the primary therapeutic aim. However, experimental data (obtained using mostly the transient middle cerebral artery occlusion model) indicates that progressive stroke can still develop despite successful recanalization, a process termed “reperfusion injury.” Mounting experimental evidence suggests that platelets and T cells contribute to cerebral ischemia/reperfusion injury, and ischemic stroke is increasingly considered a thrombo-inflammatory disease. The interaction of von Willebrand factor and its receptor on the platelet surface, glycoprotein Ib, as well as many activatory platelet receptors and platelet degranulation contribute to secondary infarct growth in this setting. In contrast, interference with GPIIb/IIIa-dependent platelet aggregation and thrombus formation does not improve the outcome of acute brain ischemia but dramatically increases the susceptibility to intracranial hemorrhage. Here, we summarize the current understanding of the mechanisms and the potential translational impact of platelet contributions to cerebral ischemia/reperfusion injury.Funding Information
- Deutsche Forschungsgemeinschaft (374031971 – CRC/TR 240)
This publication has 118 references indexed in Scilit:
- Preclinical stroke research – advantages and disadvantages of the most common rodent models of focal ischaemiaBritish Journal of Pharmacology, 2011
- Ischaemic stroke: a thrombo‐inflammatory disease?Journal Of Physiology-London, 2011
- Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndromeNature Genetics, 2011
- NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granulesNature Genetics, 2011
- Munc13-4 is a limiting factor in the pathway required for platelet granule release and hemostasisBlood, 2010
- Deficiency of PAR4 Attenuates Cerebral Ischemia/Reperfusion Injury in MiceJournal of Cerebral Blood Flow & Metabolism, 2010
- von Willebrand factor–cleaving protease ADAMTS13 reduces ischemic brain injury in experimental strokeBlood, 2009
- Platelet α-granules: Basic biology and clinical correlatesBlood Reviews, 2009
- Inflammation induces hemorrhage in thrombocytopeniaBlood, 2008
- The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosisProceedings of the National Academy of Sciences of the United States of America, 2006